コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 good and rapid method for evaluation of the coronary anatomy and for early detection and grading of
3 ACb progressed from 1 to 399 to CAC5y>/=400, coronary and total cardiovascular risk were nearly 2-fol
4 ome because patients have generally a normal coronary angiogram and left ventricular dysfunction, whi
5 ercise stress test, computerized tomographic coronary angiogram, and cardiovascular magnetic resonanc
7 ients were subjected to CSA procedure during coronary angiography (CSA group), and 25 patients served
8 ulness of screening with computed tomography coronary angiography (CTCA), and assess the safety and e
9 mly assigned to radial or femoral access for coronary angiography and percutaneous intervention, and
12 trials of routine versus selective invasive coronary angiography have high rates of crossover from c
14 nting a case of critical hand ischemia after coronary angiography performed through radial access des
16 raphy by visual estimate and by quantitative coronary angiography when compared with FFR and evaluate
17 y manifestation, with indications to undergo coronary angiography with intent to perform percutaneous
18 ical outcome of patients with ACS undergoing coronary angiography, as compared with patients with sta
20 rospective registry of patients referred for coronary angiography, the goal of this study was to deve
22 cardiovascular event (myocardial infarction, coronary angioplasty, coronary artery bypass graft surge
24 (LCx), right coronary artery, and all three coronary arteries combined were compared with microspher
25 d in EC overlying atherosclerotic plaques in coronary arteries from patients with ischemic heart dise
29 ary blood flow and vasodilatory responses of coronary arterioles were evaluated in all groups at the
30 idance when performing unprotected left main coronary artery (LMCA) percutaneous coronary interventio
31 as obtained during a 1-minute proximal right coronary artery (RCA) and left coronary artery balloon o
34 namically significant stenosis in at least 1 coronary artery as indicated by a fractional flow reserv
35 roximal right coronary artery (RCA) and left coronary artery balloon occlusion at baseline before and
36 without acute coronary syndromes or previous coronary artery bypass graft surgery in periods before (
37 artery (RA) can improve clinical outcomes in coronary artery bypass graft surgery remains unclear.
38 nts with no acute coronary syndrome/no prior coronary artery bypass graft surgery that were rated as
41 lectomy (189229 patients at 1876 hospitals), coronary artery bypass grafting (CABG) (218940 patients
42 unclear whether revascularization by either coronary artery bypass grafting (CABG) or percutaneous c
43 ubgroup analysis of patients undergoing only coronary artery bypass grafting, and results were simila
45 utaneous coronary intervention (28%), urgent coronary artery bypass surgery (27.5%), maternal mortali
48 ciation between the polygenic risk score and coronary artery calcification (CARDIA) and carotid arter
50 , iliofemoral, and abdominal aortic plaques; coronary artery calcification; serum biomarkers; and lif
53 sessed the relationships among adult height, coronary artery calcium (CAC) score, incident atheroscle
56 lated with QTc prolongation in patients with coronary artery disease (CAD) and investigate the effect
58 tly associated with cardiovascular events in coronary artery disease (CAD) patients and reducing the
60 rmediate pretest probability for obstructive coronary artery disease (CAD) were randomly assigned to
61 etically higher calcium had a higher risk of coronary artery disease (CAD), myocardial infarction (MI
63 other or medical treatment in patients with coronary artery disease and left ventricular ejection fr
64 ated to treatment (two in the control group [coronary artery disease and multiorgan failure] and thre
65 he context of a recent GWAS meta-analysis of coronary artery disease and provide a list of targeted e
68 CT coronary angiography revealed positive coronary artery disease findings in 16 patients; LAD was
69 -wide Replication and Meta-analysis Plus the Coronary Artery Disease Genetics (CardiogramplusC4D) con
70 s (N = up to 61079 individuals) and from the Coronary Artery Disease Genome-wide Replication and Meta
72 ing process of ACS patients with obstructive coronary artery disease is associated with a high reclas
73 ASA sensitivity with known/suspected stable coronary artery disease or presenting with an acute coro
75 ic role of elevated WBC across a spectrum of coronary artery disease presentations are warranted.
76 55+/-10 years), mostly with an intermediate coronary artery disease probability, between cardiac CT
77 hemorrhagic shock in swine with preexisting coronary artery disease reduced renal dysfunction and ca
78 e genetic association between rs11556924 and coronary artery disease risk by characterizing its effec
79 e-industrial lifestyle and low prevalence of coronary artery disease risk factors, we examined the Ts
80 similar age, sex, and low Framingham 10-year coronary artery disease risk scores with an echocardiogr
81 ing the total number of loci associated with coronary artery disease to 95 at the time of analysis.
82 reserve with best MT in patients with stable coronary artery disease to assess clinical outcomes and
83 mparison to Functional Testing for Suspected Coronary Artery Disease) prospectively randomized 350 pa
84 gists by 2 1 method required the presence of coronary artery disease, a common interpretation of the
85 outh), BMI, height, systolic blood pressure, coronary artery disease, and type 2 diabetes using data
86 sterol, low-density lipoprotein cholesterol, coronary artery disease, C-reactive protein, HbA1c, heig
87 undergoing initial evaluation for suspected coronary artery disease, coronary CTA was associated wit
88 nfarction in the past 20 years, multi-vessel coronary artery disease, history of stable or unstable a
89 n risk for five vascular diseases, including coronary artery disease, migraine headache, cervical art
90 stable outpatients presenting with suspected coronary artery disease, most patients experiencing clin
91 ion (T2MI2007); and 1 method did not require coronary artery disease, the 2012 universal definition (
101 .G202V HAND2 variant associated with CHD and coronary artery diseases found in a large Lebanese famil
102 ake of normal and PE STBEVs by primary human coronary artery endothelial cells (HCAEC) and the effect
103 NFalpha and cigarette smoke extract on human coronary artery endothelial cells under oscillatory, nor
106 ta support a model in which DACH1 stimulates coronary artery growth by activating Cxcl12 expression a
108 B6sv129-mice were subjected to in vivo left coronary artery ligation for 30 minutes followed by 72 h
114 e been used in clinical research for imaging coronary artery plaque, and ongoing clinical studies are
115 d white men and women from the observational Coronary Artery Risk Development in Young Adults study,
116 and 2 observational cohort studies (CARDIA [Coronary Artery Risk Development in Young Adults] and Bi
118 the LAD, left circumflex artery (LCx), right coronary artery, and all three coronary arteries combine
120 ence imaging detected nanoparticles in human coronary artery-sized atheroma in vivo (P<0.05 versus re
122 dhood obesity with obesity and complexity of coronary atherosclerosis (SYNTAX score) in a cohort of 3
124 CL5 and molecular phenotypes associated with coronary atherosclerosis severity in patients at least 6
128 fetime AAS dose was strongly associated with coronary atherosclerotic burden (increase [95% confidenc
132 ew possibilities to measure maximal absolute coronary blood flow and minimal microcirculatory resista
134 oglycerin causes changes in the systemic and coronary circulation that combine to reduce myocardial o
137 ders at 193 North American sites interpreted coronary computed tomographic (CT) angiography as part o
139 bstructive LM CAD was frequently detected on coronary computed tomographic angiography and strongly a
141 tial noninvasive cardiac testing with either coronary computed tomography angiography (CTA) or functi
147 ation for suspected coronary artery disease, coronary CTA was associated with greater use of statins,
148 (HR: 1.95; 95% CI: 1.72 to 2.21), unheralded coronary death (HR: 1.78; 95% CI: 1.51 to 2.10), abdomin
149 beverage intake with risk of mortality from coronary diseases, diabetes, or cancer, but few studies
152 t fluctuation is a risk factor for death and coronary events in patients without cardiovascular disea
155 value of noninvasively assessing indices of coronary flow for diagnosing coronary microvascular dysf
156 rements of fractional flow reserve (FFR) and coronary flow reserve (CFR) and the index of microcircul
157 idated for absolute myocardial perfusion and coronary flow reserve (CFR) by positron emission tomogra
159 using speckle-tracking echocardiography, (2) coronary flow reserve, (3) pulse wave velocity and augme
160 rmine the long-term risks of acute and fatal coronary heart disease (CHD) events after sepsis hospita
161 telomere length (TL) to be a risk factor for coronary heart disease (CHD), and recently the associati
162 differences of incident heart failure (HF), coronary heart disease (CHD), and stroke in participants
168 .99 to 1.32), but higher risks of death from coronary heart disease (HR: 1.45; 95% CI: 1.21 to 1.74),
170 ntration with first-ever CVD outcomes (i.e., coronary heart disease [CHD], stroke, or the combination
172 recognized as an independent risk factor for coronary heart disease and cardiovascular mortality.
174 INTERPRETATION: In Chinese patients with coronary heart disease and impaired glucose tolerance, a
175 century, then the decline in mortality from coronary heart disease and stroke has been the success s
177 /=190 mg/dL, pravastatin reduced the risk of coronary heart disease by 27% (P=0.033) and major advers
179 ring the initial trial phase and the risk of coronary heart disease death, cardiovascular death, and
182 the effect of the genetic score on decreased coronary heart disease risk extended beyond its effect o
184 tive cohorts, carriers of CHIP had a risk of coronary heart disease that was 1.9 times as great as in
185 lood cells and associated such presence with coronary heart disease using samples from four case-cont
186 hat the CETP inhibitor anacetrapib decreased coronary heart disease when added to statin therapy.
188 ariants at the CXCR4 locus with the risk for coronary heart disease, along with CXCR4 transcript expr
189 ad suffered from CVD, 4.9% had suffered from coronary heart disease, and 2.6% had experienced a strok
190 dent myocardial infarction or death owing to coronary heart disease, and stroke, defined as the first
191 recommendations for patients with prevalent coronary heart disease, and we offer recommendations, wh
195 y of APOC3 has been shown to protect against coronary heart disease; we identified APOC3 homozygous p
196 nfirmed that (68)Ga-DOTATATE offers superior coronary imaging, excellent macrophage specificity, and
198 comprised CVD death, myocardial infarction, coronary insufficiency, index admission for heart failur
199 echanical support (28%), urgent percutaneous coronary intervention (28%), urgent coronary artery bypa
200 s with STEMI undergoing primary percutaneous coronary intervention (n=1604; mean age, 61+/-12 years;
202 rtery bypass grafting (CABG) or percutaneous coronary intervention (PCI) carries benefits or risks in
203 and white patients treated with percutaneous coronary intervention (PCI) in the Veterans Affairs (VA)
206 infarction (STEMI), the use of percutaneous coronary intervention (PCI) to restore blood flow in an
207 eft main coronary artery (LMCA) percutaneous coronary intervention (PCI), but the overall picture rem
209 Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI] [CHAMPION PHOENIX] [CHAMPION
212 relief of coronary obstruction, percutaneous coronary intervention has become a standard-of-care proc
213 w marking its 40th anniversary, percutaneous coronary intervention has become one of the most common
216 y), 4222 patients who underwent percutaneous coronary intervention in the United States and Europe be
217 e acute stage, intended primary percutaneous coronary intervention increased from 12% (1995) to 76% (
218 ciated with changes in rates of percutaneous coronary intervention or in-hospital mortality in New Yo
219 ETHODS AND We analyzed 1253 CTO percutaneous coronary intervention procedures performed according to
220 ly has led to worse outcomes in percutaneous coronary intervention procedures performed through the t
221 ral complexity, shorter primary percutaneous coronary intervention time was associated with an increa
222 Patients (n=15 003) underwent percutaneous coronary intervention to SVG in England and Wales during
224 ction (MI) treated with primary percutaneous coronary intervention were randomized to prasugrel or ti
225 ete revascularization following percutaneous coronary intervention were randomized to ranolazine vers
226 rates of ischemic events during percutaneous coronary intervention without an increase in severe blee
227 ariables (male sex and previous percutaneous coronary intervention) and 4 biomarkers (midkine, adipon
228 omplete Revascularization after Percutaneous Coronary Intervention) trial, a clinical trial in which
229 s and additionally into primary percutaneous coronary intervention, fibrinolysis, or no reperfusion.
230 e angina, previous multi-vessel percutaneous coronary intervention, or previous multi-vessel coronary
231 y survive the first month after percutaneous coronary intervention, their prognosis is comparable to
232 30 patients were transported to percutaneous coronary intervention-capable hospitals, including 974 i
246 sing indices of coronary flow for diagnosing coronary microvascular dysfunction; in certain diseases,
247 function; in certain diseases, the degree of coronary microvascular impairment carries important prog
249 ythmias (VAs) were subjected to percutaneous coronary occlusion to induce myocardial infarction.
251 the Effect of Iso-osmolar Contrast Medium on Coronary Opacification and Heart Rhythm in Coronary CT A
252 single-center cohort of patients undergoing coronary or peripheral angiography with or without inter
253 djustments for age, sex, study site, primary coronary percutaneous intervention (PCI), and norepineph
254 patients with psoriasis had increased total coronary plaque burden (1.22+/-0.31 versus 1.04+/-0.22,
256 th statin therapy (WOSCOPS [West of Scotland Coronary Prevention Study]; n=4910) and 2 observational
257 ores in the mid-range (4 to 6) indicate that coronary revascularization may be appropriate for the cl
258 Recurrent MI, CHD events (recurrent MI or a coronary revascularization procedure), and mortality wer
259 ular outcomes (death, myocardial infarction, coronary revascularization, or cerebrovascular events) i
266 tivation and subsequent differentiation into coronary smooth muscle, and restores Wt1 activity upon M
267 rrelation between angiographic assessment of coronary stenoses and fractional flow reserve (FFR) is w
268 FR), an index of the hemodynamic severity of coronary stenoses, is derived from invasive measurements
271 s older than 18 years with an indication for coronary stenting were enrolled, and 11648 (mean age, 61
274 tiplatelet and anticoagulant agents, and new coronary stents will continue the journey to achieve thi
275 the incidence of AKI in patients with acute coronary syndrome (ACS) enrolled in the MATRIX-Access (M
277 s nonculprit arteries in patients with acute coronary syndrome (median difference: 0.69; interquartil
278 patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) and an elevated cardiac tro
279 of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) study between April 1,
280 between WBC and MACE was consistent in acute coronary syndrome and non-acute coronary syndrome presen
283 centrations in patients with suspected acute coronary syndrome in which the diagnosis was adjudicated
284 rt-term mortality and complications in acute coronary syndrome patients treated with extracorporeal c
285 ent in acute coronary syndrome and non-acute coronary syndrome presentations (interaction P=0.15).
286 tal or nonfatal myocardial infarction, acute coronary syndrome without myocardial infarction, coronar
287 mong patients with stable angina or an acute coronary syndrome, an iFR-guided revascularization strat
288 heart failure, and hospitalization for acute coronary syndrome, and the incidence of acute pancreatit
289 abilized individuals within 10 days of acute coronary syndrome, combination therapy seemed to be more
291 y artery disease or presenting with an acute coronary syndrome, including ST-segment-elevation myocar
292 , with or without ST-segment elevation acute coronary syndrome, were randomly assigned to radial or f
294 tal number of PCIs in patients with no acute coronary syndrome/no prior coronary artery bypass graft
295 formed in New York in patients without acute coronary syndromes or previous coronary artery bypass gr
296 zed participants with non-ST-elevation acute coronary syndromes or stable angina and to evaluate long
297 ve Versus Conservative Treatment in Unstable Coronary Syndromes) trial compared early invasive strate
299 temperature through a dedicated catheter for coronary thermodilution induces steady-state maximal hyp
300 ctors of >/=70% stenosis in at least 1 major coronary vessel were identified from >200 candidate vari
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。